Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma

Cisplatin is one of the most effective chemotherapeutic agents commonly used for several malignancies including oral squamous cell carcinoma (OSCC). Although cisplatin resistance is a major obstacle to effective treatment and is associated with poor prognosis of OSCC patients, the molecular mechanis...

全面介紹

Na minha lista:
書目詳細資料
發表在:Int J Mol Sci
Main Authors: Suenaga, Naoki, Kuramitsu, Mimi, Komure, Kanae, Kanemaru, Ayumi, Takano, Kanako, Ozeki, Kazuya, Nishimura, Yuka, Yoshida, Ryoji, Nakayama, Hideki, Shinriki, Satoru, Saito, Hideyuki, Jono, Hirofumi
格式: Artigo
語言:Inglês
出版: MDPI 2019
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6829433/
https://ncbi.nlm.nih.gov/pubmed/31635163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20205194
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍